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Kevin Ashton coined the term “Internet of
Things” in 2009 in the setting of supply
chain management,1 but since that time,
the Internet of Things (IoT) has had an
impact on many other markets. Over the
past several years, advances in computing
and sensing have sparked the emergence
of the IoT for health care. The IoT refers
to a connection of smart objects such as
appliances, sensors, controllers, wearables,
andmedical devices to the Internet. Overall,
the IoT health care market is predicted to
grow from 32.4 billion in 2015 to 163 billion
by the year 2020.2 In 2015, there were al-
ready 25 billion Internet-connected devices,
which is double the number of humans on
Earth.3 In addition, the number of IoT
devices will have unprecedented growth
and is expected to increase to more than 50
billion by 2020.3 Within the IoT, wearable
devices and sensors alonewill grow tomore
than 118 million devices predicted to be
sold by 2018.4
As health care moves away from tra-
ditional encounter- and office-based care
paradigmstomorecontinuous interactions
between the patient and the health care
system, there is an unparalleled opportunity
to leverage emerging technologies to create
an ecosystem with the patient at the
center. It is now possible to track various
types of data in the patient’s own envi-
ronment. Examples include accelerom-
eter data (physical activity and intensity),
temperature, heart rate and heart rate
variability, blood pressure, sleep, caloric
intake/expenditure, brain wave activity,
pulse oximetry, glucose, and other biometric
data. Wristbands and smartwatches cur-
rently predominate the fitness wearables
market,5 but there will be a shift toward
smart garments by 2020.6 There are also
several ingestible and implantable sensors
for tracking biometric data that already
have or are currently undergoingUS Food
andDrugAdministration approval. Beyond
wearables, sensors can now be attached
to appliances, objects, and the environ-
ment to detect carbon dioxide and carbon
monoxide, particulate matter, ambient
room temperature, light, and allergens
such as pollen.
Information technology was cited as a
key requirement forbuildingahigh-quality
cancer care delivery system by the Institute
of Medicine and also as the foundation for
a learning health care system.7 This vision
for digitally capturing the health care ex-
perience for “real-time generation and
application of knowledge for care im-
provement” has made substantial prog-
ress since that report in 2009. One exemplar
is CancerLinQ,8 which is an initiative of
the American Society of Clinical Oncol-
ogy for aggregating and analyzing data
from electronic health records, clinical
trials, and clinical practice guidelines.
Recently, CancerLinQ and the Cancer In-
formatics for Cancer Centers announced
a collaboration to apply big data method-
ologies to drive discovery in cancer care.
Understanding health care delivery through
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real-time, large-scale monitoring and evaluation is an im-
portant step toward actualizing a true learning health care
information technology system that targets the specific issues
unique to cancer care.
Until recently, electronic health records have not in-
corporated patient-generated health data (PGHD) in cancer
care. PGHD includes patient-reported outcomes, medical/
wearable device data, and other sensor-generated data from
within the patient’s home environment. Because patients
spend most of their lives outside the walls of the clinic and
hospital, IoT technologies that generate PGHD provide an
unparalleled opportunity to obtain a more holistic longitu-
dinal view of the health of a patient with cancer. For example,
one could envision that a patient with cancer who also has
heart failure could have a smart home environment which has
sensor-enabled doors, floors, refrigerator/freezer, pillboxes,
toothbrushes, bed, andmirrors coupledwith wearable sensors
for continuous or intermittent monitoring of heart rate, elec-
trocardiogram, pulse oximetry, respiratory rate, body temper-
ature, galvanic skin response, hydration, weight, and gait (Fig 1).
The patient’s context within the IoT ecosystem could be further
enhanced with data streams from social media, consumer data
(purchases), and geographic information systems and from
scanning the environment for audioand/orvoicedata.Advanced
computational and mathematical analytic approaches could
process and aggregate these data into actionable information
to shape self-management or clinical decisions. In this IoT
ecosystem, an oncologist could be notified if a patient has not
been out of bed or out of their room or if their pillbox has not
been opened for several days. These signals from within the
IoT data would provide an opportunity for the oncologist to
check in with the patient and have the patient answer an
electronic patient-reported outcome questionnaire via the
patient portal. The oncologist could also send a textmessage to
the patient or caregiver to determine whether the patient is
having intractable pain or their physical function has declined
such that they are unable to get out of bed to reach the pillbox
and have therefore missed doses of their oral chemotherapy
medication.
It is also conceivable that, in the near future, most of the
data to inform clinical care will be collected outside clinical
settings and will potentially provide richer details about the
patient. For frail and elderly patients with cancer, remote
monitoringusingPGHDand the IoTcould help keeppatients
out of the hospital so they can instead remain in their homes
and still have any adverse symptomatic events or acute
exacerbations managed effectively. With the IoT, providers
could identify variance or deviations from baseline measures
and alert the patient or caregiver to check in or to seek
emergency care.
Integrating the IoT to improve the quality of cancer care
faces several challenges, including security and privacy, data
standards and interoperability, data provenance and owner-
ship, and workflow integration into clinical care. As the num-
ber of Internet-connected devices and objects increases, the
number of potential entry points for cyberattacks increases.
Streaming sensitive health data from IoT devices presents an
attractive target for data thieves. Ensuring the security and
privacy of these data will be paramount. In an extreme case, a
medical device or sensor could be hacked in real time, which
could have potentially fatal consequences. In another case,
data from a device could be stolen, thus potentially revealing
sensitive health information.
There are a number of challenges regarding data standards
and interoperability. The accuracy of data from consumer
devices isvariable,andsomedevicesperformbetter thanothers
for physical activity and heart rate.9,10 In the case of physical
activity data, the raw accelerometer data generally are pro-
cessed by proprietary algorithms that can vary by device and
are often updatedwithout notice to the user. Standardizing the
outputs of these data across devices and performing validation
studies in various patient populations will improve the use of
these data across patient populations. There are also nu-
merous standards and ontologies, which make mapping data
from different data streams extremely difficult. Moreover,
there will likely be numerous types of devices and sensors
within the IoT health ecosystem that need to exchange and
interpret data sharedwith each other andwith electronic health
record systems. Thus, interoperability on a foundational,
structural, and semantic level will be paramount.
Data provenance and ownership is another broad concern
identified by patients, providers, health care systems, and
policymakers. The ability todemarcate patient-generateddata
from data generated during clinical encounters is key for
bringing these types of data into the health care setting in
a way that physicians can differentiate them.11 In terms of
data ownership, there is much debate about whether PGHD
is owned by the patient or by the health care system if
the data are synchronized to the electronic health record
system or patient portal. Ultimately, data ownership issues
have important downstream effects. If patients own their
data, they have an opportunity to contribute the data for
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research purposes. Citizen science is making progress through
organizations such as PatientsLikeMe and the Patient-
Centered Outcomes Research Institute, which serve as the
infrastructure for contributing PGHD to research on a larger
scale. If patients do not retain ownership of their data, scaling
citizen science efforts will be difficult. Currently, little is
known about the patient experience in populations not
captured within cancer trials. Thus, the IoT could provide an
opportunity to better understand these populations, their
outcomes, and the influence of contextual factors on their
health and could move beyond the information currently
streamed from consumer fitness wearables.
Integration of IoT andPGHD into clinical care processes is
challenging because the evidence base is evolving. First, it is
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FIG 1. Conceptual model of an “Internet of Things” ecosystem for health. EEG, electroencephalogram; EHR, electronic health record; EMG, electromyogram.
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unclear which types of patients with cancer would benefit most
from being monitored by using IoT technologies, which types
ofdatawill benecessary toaccuratelycapture thequalityof care
and improve patient outcomes, and how frequently data
should be sampled (continuously v intermittently). Second,
while a recent national survey showed that patients are quite
willing to exchange information about vital signs and
symptoms over a mobile phone or tablet,12 little is known
about whether patients would be willing to be continuously
monitored with IoT technologies that might be perceived
as being more obtrusive. Third, providers who are already
inundated with data are wary about the impact of additional
data on their workflows and workload.11 Finally, there is
little guidance regarding how frequently these data should
be brought into electronic health record systems as part of
the medical record and how they should be presented to
providers to facilitate clinical decision making. In some
instances, bringing in continuous streams of IoT data without
appropriate alerts and notifications to inform providers about
abnormalities in real time could present safety issues. For
example, a patient with breast cancer who is receiving
anthracycline, which is potentially cardiotoxic, could develop a
life-threatening arrhythmia that could be detected by using a
continuous heart rate sensor. If her data were not monitored in
real time with an alert generated to notify the physician on call,
missing that event could have serious consequences.
As the IoTecosystemexpandsover thenext fewyears, there
will be new opportunities to quantify, evaluate, and monitor a
patient’s biometrics, home, and environment. This will provide
researchers and oncologists with an exceptional opportunity to
better understand how a patient’s unique ecosystem contrib-
utes to their overall health and long-term outcomes during and
after cancer treatment. Although there are known environ-
mental exposures that contribute to cancer risk, IoT data may
be able to enhance our understanding of the microenviron-
ment’s contribution to an individual’s cancer risk. Overall,
these insights will allow for greater precision and tailoring of
clinical recommendations and treatment options and ulti-
mately improve the patient’s experience longitudinally.
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